Trisha Garrett
Family Medicine · Washington, INNPI 1619261369
Payments from drug & device makers
Across 174 payments — averaging $16.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$363
- Amgen$345
- AstraZeneca$275
- Lilly USA, LLC$230
- GSK$171
- Pfizer$164
- plus $1K from 30 others
What the payments were for
- Food & beverage$2,78299%
- Education$321%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 19 | $363 |
| Amgen | 20 | $345 |
| AstraZeneca | 18 | $275 |
| Lilly USA, LLC | 15 | $230 |
| GSK | 12 | $171 |
| Pfizer | 11 | $164 |
| AbbVie(2 entities) | 8 | $131 |
| Otsuka America Pharmaceutical, Inc. | 5 | $89 |
| Phathom Pharmaceuticals, Inc. | 5 | $86 |
| Novartis | 5 | $73 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $73 |
| Mylan Specialty L.p. | 4 | $70 |
| Boehringer Ingelheim | 4 | $62 |
| Philips North America LLC | 4 | $60 |
| Grifols USA, LLC | 4 | $51 |
| Merck | 4 | $50 |
| Eisai Inc. | 3 | $50 |
| Bristol Myers Squibb | 3 | $43 |
| Viatris Specialty LLC | 2 | $37 |
| Ironwood Pharmaceuticals, Inc | 2 | $37 |
| Abiomed | 1 | $36 |
| Axsome Therapeutics, Inc. | 2 | $35 |
| Exact Sciences | 2 | $35 |
| Johnson & Johnson | 2 | $35 |
| Kowa Pharmaceuticals America, Inc. | 2 | $30 |
| Amarin Pharma, Inc. | 2 | $30 |
| Sonex Health, Inc. | 1 | $19 |
| Abbott | 1 | $18 |
| Incyte Corporation | 1 | $18 |
| Ardelyx, Inc. | 1 | $16 |
| Shire North American Group Inc | 1 | $16 |
| Sunovion Pharmaceuticals Inc. | 1 | $15 |
| Teva Pharmaceuticals USA, Inc. | 1 | $14 |
| Jazz Pharmaceuticals Inc. | 1 | $13 |
| Dexcom, Inc. | 1 | $13 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $11 |
How this compares
$2,814 in reported general payments places this provider in the 75th percentile of 2,709 family medicine providers in Indiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 74 | $79,709 |
| EliquisApixaban | 55 | $47,209 |
| JardianceEmpagliflozin | 39 | $37,529 |
| JanuviaSitagliptin Phosphate | 49 | $34,733 |
| Janumet XrSitagliptin Phos/Metformin Hcl | 37 | $31,628 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 29 | $30,182 |
| XareltoRivaroxaban | 22 | $21,115 |
| TrulicityDulaglutide | 16 | $15,190 |
| LinzessLinaclotide | 21 | $13,278 |
| InvokanaCanagliflozin | 11 | $13,076 |
| Breo ElliptaFluticasone/Vilanterol | 19 | $12,173 |
| Advair HfaFluticasone Propion/Salmeterol | 25 | $9,431 |
| Tresiba Flextouch U-100Insulin Degludec | 18 | $8,949 |
| SymbicortBudesonide/Formoterol Fumarate | 20 | $6,723 |
| Incruse ElliptaUmeclidinium Bromide | 11 | $6,066 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $363 | $79,70974 claims |
| MerckJanuvia, Janumet Xr | $50 | $66,36186 claims |
| GSKTrelegy Ellipta, Breo Ellipta, Incruse Ellipta | $171 | $48,42059 claims |
| PfizerEliquis | $164 | $47,20955 claims |
| Boehringer IngelheimJardiance | $62 | $37,52939 claims |
| Johnson & JohnsonXarelto, Invokana | $35 | $34,19133 claims |
| AbbVieLinzess, Synthroid | $131 | $16,66276 claims |
| Lilly USA, LLCTrulicity | $230 | $15,19016 claims |
| AstraZenecaSymbicort | $275 | $6,72320 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,709 family medicine providers in Indiana.
Other family medicine in Washington
- Blair BrengleIndianapolis$10.6M
- Laura HelmanMishawaka$4M
- J Christopher SartoreEvansville$3.9M
- Hubert ReyesEvansville$3.2M
- David SchultzEvansville$3M
- Steven SmithIndianapolis$2.5M
- Renee Michelle GalenNewburgh$2.1M
- Eric HewittAvon$1.7M
- Alexander Dela LlanaEvansville$1.6M
- Jonathan ConditMuncie$1.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.